RORA and ovarian carcinoma: LncRNA WDFY3-AS2 and mRNA RORA are both involved in suppression of ovarian cancer by the WDFY3-AS2/miR-18a/RORA axis, in which miR-18a is reported to be an oncogene (Li W. et al., 2020).